These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 7832430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM, Chen RC, Chiueh CC.
    Ann N Y Acad Sci; 2000 Oct; 899():255-61. PubMed ID: 10863544
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
    Schmidt DE, Ebert MH, Lynn JC, Whetsell WO.
    J Neural Transm (Vienna); 1997 Oct; 104(8-9):875-85. PubMed ID: 9451719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Oct; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J, Cheng FC, Yang Z, Dryhurst G.
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR, Zhu ZT, Zhu XZ.
    Life Sci; 2000 Jun 08; 67(3):241-50. PubMed ID: 10983868
    [Abstract] [Full Text] [Related]

  • 16. New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
    Gerlach M, Desser H, Youdim MB, Riederer P.
    J Neural Transm Suppl; 1996 Jun 08; 48():7-21. PubMed ID: 8988458
    [Abstract] [Full Text] [Related]

  • 17. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Jun 08; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 18. [Medicamentous strategy for improving the quality of life in the senescence].
    Knoll J.
    Wien Med Wochenschr Suppl; 1986 Jun 08; 98():1-18. PubMed ID: 3097965
    [Abstract] [Full Text] [Related]

  • 19. (-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system.
    Knoll J.
    J Am Geriatr Soc; 1992 Aug 08; 40(8):839-47. PubMed ID: 1634730
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.
    Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G.
    Neurotox Res; 2000 Aug 08; 2(2-3):293-310. PubMed ID: 16787846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.